Department of Dermatology, Fujita Health University School of Medicine, Toyoake, Japan.
J Dermatol. 2013 Dec;40(12):998-1003. doi: 10.1111/1346-8138.12301. Epub 2013 Dec 4.
Immunoglobulin G4-related disease (IgG4-RD) is a newly recognized disease characterized by elevated serum IgG4 levels, tissue infiltration rich in IgG4(+) plasma cells. We report on a case which was first considered as pseudolymphoma from the histopathological analysis, but finally diagnosed as IgG4-related skin lesions. As the morphological features of cutaneous involvement of IgG4-RD are consistent with those of cutaneous pseudolymphoma, we tried immunostaining past potential cases of IgG4-RD. Thirty-two skin specimens (15 men and 17 women; mean age, 53 years) diagnosed as having pseudolymphoma were retrieved from the archives to conduct hematoxylin-eosin, IgG and IgG4 staining. Out of the 32 cases of cutaneous pseudolymphoma, germinal center formation was seen in 22 cases, and moderate-severe fibrosis was seen in seven cases. Eleven cases showed more than 10 IgG4(+) plasma cell infiltration/high-power field, and among these 11 cases, seven cases (22%) showed A ratio of IgG4(+)/IgG(+) cells of more than 40%. Thus, out of the 32 cases of cutaneous pseudolymphomas, two cases (6.3%) satisfied IgG4-RD histopathological diagnostic criteria. As clinical presentations and histopathological features of skin involvement of IgG4-RD are analogous to cutaneous B-cell pseudolymphoma, careful identification is required through systemic examination, serum IgG4 measurement and other means.
免疫球蛋白 G4 相关疾病(IgG4-RD)是一种新认识的疾病,其特征为血清 IgG4 水平升高,组织浸润富含 IgG4(+)浆细胞。我们报告了一例最初从组织病理学分析被认为是假性淋巴瘤的病例,但最终诊断为 IgG4 相关皮肤病变。由于 IgG4-RD 的皮肤受累的形态学特征与皮肤假性淋巴瘤的特征一致,因此我们尝试对潜在的 IgG4-RD 病例进行免疫组化染色。从档案中检索了 32 例被诊断为假性淋巴瘤的皮肤标本(15 名男性和 17 名女性;平均年龄 53 岁)进行苏木精-伊红、IgG 和 IgG4 染色。在 32 例皮肤假性淋巴瘤中,有 22 例可见生发中心形成,7 例可见中重度纤维化。11 例显示超过 10 个 IgG4(+)浆细胞浸润/高倍视野,其中 11 例中有 7 例(22%)显示 IgG4(+)/IgG(+)细胞的 A 比值大于 40%。因此,在 32 例皮肤假性淋巴瘤中,有 2 例(6.3%)符合 IgG4-RD 组织病理学诊断标准。由于 IgG4-RD 皮肤受累的临床表现和组织病理学特征与皮肤 B 细胞假性淋巴瘤相似,因此需要通过系统检查、血清 IgG4 测量和其他方法进行仔细鉴别。